Cefbuperazone (BMY 25182), a new cephamycin, showed activity similar to those of moxalactam and other cephalosporin-cephamycins against aerobic and anaerobic bacteria from female genital tract infections. MICs of the antimicrobial agents were less than or equal to 16 micrograms/ml for greater than 97% of organisms tested. All of the anaerobic bacteria tested were susceptible to clindamycin, metronidazole, and chloramphenicol.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC180195 | PMC |
| http://dx.doi.org/10.1128/AAC.27.6.958 | DOI Listing |
Publication Analysis
Top Keywords
antimicrobial agents
8
female genital
8
genital tract
8
anaerobic bacteria
8
vitro activity
4
activity cefbuperazone
4
cefbuperazone antimicrobial
4
agents isolates
4
isolates female
4
tract cefbuperazone
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!